The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches

The Role of ERα and ERβ in Castration-Resistant Prostate Cancer and Current Therapeutic Approaches

Castration-resistant prostate cancer, or CRPC, is an aggressive stage of prostate cancer (PCa) in which PCa cells invade nearby or other parts of the body. When a patient with PCa goes through androgen deprivation therapy (ADT) and the cancer comes back or worsens, this is called CRPC. Instead of an...

Full description

Bibliographic Details
Main Authors: Nur Erysha Sabrina Jefferi, Asma’ ‘Afifah Shamhari, Nur Khayrin Zulaikha Noor Azhar, Joyce Goh Yi Shin, Nur Annisa Mohd Kharir, Muhammad Afiq Azhar, Zariyantey Abd Hamid, Siti Balkis Budin, Izatus Shima Taib
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biomedicines
Subjects:
castration-resistant prostate cancer
estrogen receptor
anti-estrogen therapy
antioxidant
immunotherapy
Online Access:https://www.mdpi.com/2227-9059/11/3/826

Internet

https://www.mdpi.com/2227-9059/11/3/826

Similar Items